Publikace
- TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study2021 | 2. lékařská fakulta
- Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study2020 | 2. lékařská fakulta
- Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset2020 | 2. lékařská fakulta
- Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study2020 | 2. lékařská fakulta
- Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children2020 | 2. lékařská fakulta
- Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study2019 | 2. lékařská fakulta
- Osteosarkom: současné možnosti diagnostiky a léčby2011 | 2. lékařská fakulta
- The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium2024 | 2. lékařská fakulta
- Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study2024 | 2. lékařská fakulta
- Parenthood for childhood cancer survivors: unfounded fear of cancer development in offspring and related health behaviors2024 | 2. lékařská fakulta
Loading network view...